Conceptio › Archive › HAL (France)
HAL (France)open access

Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

Tina Cascone et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
1, 0
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 208802
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.